Cargando…
Plasma Biomarkers for Monitoring Brain Pathophysiology in FMR1 Premutation Carriers
Premutation carriers have a 55–200 CGG expansion in the fragile X mental retardation 1 (FMR1) gene. Currently, 1.5 million individuals are affected in the United States, and carriers are at risk of developing the late-onset neurodegenerative disorder Fragile X-associated tremor ataxia syndrome (FXTA...
Autores principales: | Giulivi, Cecilia, Napoli, Eleonora, Tassone, Flora, Halmai, Julian, Hagerman, Randi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981605/ https://www.ncbi.nlm.nih.gov/pubmed/27570505 http://dx.doi.org/10.3389/fnmol.2016.00071 |
Ejemplares similares
-
Characterization of the Metabolic, Clinical and Neuropsychological Phenotype of Female Carriers of the Premutation in the X-Linked FMR1 Gene
por: Napoli, Eleonora, et al.
Publicado: (2020) -
Impact of FMR1 Premutation on Neurobehavior and Bioenergetics in Young Monozygotic Twins
por: Napoli, Eleonora, et al.
Publicado: (2018) -
Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding
por: Napoli, Eleonora, et al.
Publicado: (2016) -
Developmental profiles of infants with an FMR1 premutation
por: Wheeler, Anne C., et al.
Publicado: (2016) -
Clinical implications of somatic allele expansion in female FMR1 premutation carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2023)